Hypoxia: Clinical Trials

91 trials for Hypoxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 completed, 12 unknown, 8 terminated, 7 withdrawn. 91 Phase 1, 43 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 191Completed 52, Unknown 12, Terminated 8, Withdrawn 7, Recruiting 5, Active not recruiting 3, Not yet recruiting 3, Enrolling by invitation 1
Phase 243Completed 26, Recruiting 4, Terminated 4, Unknown 4, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1

Follow Hypoxia: new trials by email Literature Review of Hypoxia trials Research Report on Hypoxia

Trials (filtered) newest first · largest first

All 91 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy
Wharton's jelly-derived mesenchymal stem cells, 0.9 % Normal Saline - Hypoxic-Ischemic Encephalopathy, Neonatal, Brain Injuries, Hypoxic-Ischemic
Phase 1 / Phase 2Not yet recruitingMahidol University402026-09-152026-09-02
Dose-Escalation Study of Artesunate Patients With IPF
Artesuante, Placebo capsules - Idiopathic Pulmonary Fibrosis
Phase 1RecruitingJoseph C. Wu152026-08-012026-08-11
Hydrogen In Neonatal Encephalopathy (HIE) Trial
Hydrogen Gas (H2) - HIE, Hypoxic-Ischemic Encephalopathy
Phase 1Not yet recruitingBoston Children's Hospital542026-03-012026-02-17
A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury
Metformin - Hypoxic-Ischemic Encephalopathy, HIE
Phase 1Enrolling by invitationBoston Children's Hospital302025-10-012026-02-17
CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors
CD73/AXL.HypoSti.CAR-T cells, Albumin-Bound Paclitaxel, Cyclophosphamide - Solid Tumor
Phase 1 / Phase 2Not yet recruitingChinese PLA General Hospital302025-05-012025-04-22
To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.
Placebo drug ( normal saline ), neostigmine (reversal agent) - Tachycardia, Hypertension
Phase 1 / Phase 2CompletedZiauddin University1002025-03-122025-07-31
Dose Optimization of Caffeine for HIE
Caffeine citrate 20 mg/kg, Caffeine citrate 30 mg/kg - Hypoxic-Ischemic Encephalopathy
Phase 1Active not recruitingUniversity of North Carolina, Chapel Hill162024-07-262026-08-14
PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
Caffeine citrate - Acute Kidney Injury, Hypoxic-Ischemic Encephalopathy
Phase 1WithdrawnUniversity of Arkansas2024-05-082024-05-10
Advair HFA in Healthy and HAPE Predisposed Subjects
Advair HFA, Placebo - Altitude Edema
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver602023-12-122025-09-22
Metformin Treatment in Infants After Perinatal Brain Injury
Metformin Hydrochloride - Hypoxic Ischemic Encephalopathy of Newborn, Premature Birth
Phase 1TerminatedThe Hospital for Sick Children12023-05-022024-03-07
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain
Phase 1 / Phase 2RecruitingUniversity of Calgary122023-01-012026-05-01
Adenosine 2A Receptor Antagonism and AIH in ALS
Consume 20mg of istradefylline, Low Oxygen therapy, Placebo counterpart to the istradefylline drug - ALS
Phase 1 / Phase 2Active not recruitingUniversity of Florida402022-06-212026-03-27
Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease
Hypoxic Gas Mixture - Parkinson Disease, Effect of Drug
Phase 1 / Phase 2CompletedRadboud University Medical Center292022-02-222023-07-21
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Oral NKT2152 - ccRCC, Clear Cell Renal Cell Carcinoma
Phase 1 / Phase 2TerminatedNiKang Therapeutics, Inc.1202021-10-262025-11-12
Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care
Topotecan - COVID-19 Respiratory Infection
Phase 1UnknownNational University Hospital, Singapore242021-08-162021-11-04
Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn
Magnesium sulfate, Sildenafil Citrate, Isotonic saline - Persistent Pulmonary Hypertension of Newborn
Phase 1 / Phase 2RecruitingSohag University402021-06-022024-11-27
Tolerability and Efficacy of RJX in Patients With COVID-19
Rejuveinix (RJX) Active Comparator, Placebo Comparator - COVID-19, Acute Respiratory Distress Syndrome
Phase 1 / Phase 2UnknownReven Pharmaceuticals, Inc.2372021-03-252022-03-15
Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow Regulation
L-NMMA, Ketorolac, Ascorbic Acid - Hypoxia, Hypercapnia
Phase 1WithdrawnUniversity of Wisconsin, Madison2020-12-012019-01-10
Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects
Trans Sodium Crocetinate, Normal saline - SARS-CoV-2 (Covid19)
Phase 1 / Phase 2CompletedDiffusion Pharmaceuticals Inc252020-09-102022-04-14
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness
Methylphenidate - Brain Injury Traumatic Severe (Diagnosis), Coma
Phase 1Active not recruitingMassachusetts General Hospital102020-08-242025-10-29

Showing 20 of 91. Sign in to see all of them.

Narrower conditions

Hypoxia-Ischemia, Brain (34)  ·  Asphyxia Neonatorum (5)  ·  COVID-19 (5)  ·  Pancreatic Neoplasms (5)  ·  Neoplasms (4)  ·  Respiratory Distress Syndrome (4)  ·  Altitude Sickness (3)  ·  Brain Injuries (3)  ·  Head and Neck Neoplasms (3)  ·  Hypothermia (3)  ·  Lung Neoplasms (3)  ·  Motor Activity (3)  ·  Necrosis (3)  ·  Neoplasm Metastasis (3)

Broader conditions

Pathological Conditions, Signs and Symptoms (91)  ·  Signs and Symptoms (91)  ·  Signs and Symptoms, Respiratory (91)  ·  Vascular Diseases (44)  ·  Cardiovascular Diseases (42)  ·  Central Nervous System Diseases (38)  ·  Nervous System Diseases (38)  ·  Brain Diseases (37)  ·  Cerebrovascular Disorders (36)  ·  Brain Ischemia (34)  ·  Hypoxia, Brain (34)  ·  Respiratory Tract Diseases (29)  ·  Pathologic Processes (21)  ·  Lung Diseases (20)

Interventions

Saline Solution (7)  ·  TH 302 (4)  ·  Sodium Chloride (3)  ·  caffeine citrate (3)  ·  Ascorbic Acid (2)  ·  Bacterial Load (2)  ·  Bumetanide (2)  ·  Endothelium-Dependent Relaxing Factors (2)  ·  Epoetin Alfa (2)  ·  Erythropoietin (2)  ·  Injections (2)  ·  Insemination, Artificial, Homologous (2)  ·  Metformin (2)  ·  Nitric Oxide (2)  ·  Oxygen (2)

Sponsors

Threshold Pharmaceuticals (4)  ·  Radboud University Medical Center (3)  ·  University of California, San Francisco (3)  ·  BioMed Valley Discoveries, Inc (2)  ·  Boston Children's Hospital (2)  ·  Colorado State University (2)  ·  National University Hospital, Singapore (2)  ·  Sohag University (2)  ·  University of Calgary (2)  ·  University of East Anglia (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Zhengzhou University (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bayside Health (1)

Countries

United States (43)  ·  Canada (7)  ·  China (6)  ·  Netherlands (5)  ·  United Kingdom (5)  ·  Egypt (3)  ·  France (2)  ·  India (2)  ·  Japan (2)  ·  Russia (2)  ·  Sweden (2)  ·  Australia (1)  ·  Austria (1)  ·  Germany (1)  ·  Hong Kong (1)

Top investigators

Brian Kalish, MD (2)  ·  Changlian Zhu, MD, PhD (2)  ·  Christopher Bell, PhD (2)  ·  Elsayed Abdelkreem, MD, PhD (2)  ·  Katja Ruh, MD (2)  ·  Wesley M Jackson, MD, MPH (2)  ·  Yvonne W Wu, MD, MPH (2)  ·  Adrian Streinu Cercel, MD (1)  ·  Alexander V Averyanov, MD, PhD (1)  ·  Anees Sindi, FRCPC (1)  ·  Asma Abdus Salam, Consultant anaesthesiology (1)  ·  Balraj Guhan, MD (1)  ·  Baoyong Yan, Doctor (1)  ·  Barbara Smith (1)

Results publications

PMID 24524452, PMID 10492412, PMID 10793602, PMID 12717123, PMID 1356374, PMID 15199405, PMID 17122578, PMID 17893459, PMID 18668653, PMID 18977464, PMID 19172693, PMID 19183804, PMID 19883750, PMID 20385632, PMID 20576632, PMID 20631189, PMID 21195036, PMID 22091288, PMID 23008465, PMID 23133515, PMID 23372884, PMID 24388332, PMID 24815497, PMID 25439577, PMID 25512461, PMID 25765333, PMID 25794112, PMID 26680684, PMID 27535166, PMID 27632779, PMID 27756258, PMID 28729473, PMID 28890439, PMID 28949952, PMID 29016557, PMID 29261883, PMID 29769612, PMID 30573962, PMID 30661082, PMID 31261373, PMID 32813884, PMID 33046513, PMID 33362471, PMID 33415555, PMID 33626457, PMID 34155211, PMID 34482377, PMID 34667360, PMID 35473726, PMID 35836147

NIH funding

DP2HD101400 (1), K23HD111623 (1), R01HD081274 (1), R01NS066929 (1), R03DK065958 (1)